A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus

Clinical trial NCT03018938 · COMPLETED

Trial details

NCT number: NCT03018938
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2017-02-06
Primary completion: 2019-02-19
Enrollment: 814

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.